{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T13:27:14Z","timestamp":1776346034682,"version":"3.51.2"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:00:00Z","timestamp":1741392000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Our study investigated the association between hematocrit in the first two hours (HCT2h) of life and retinopathy of prematurity (ROP).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Data were obtained from an observational study of the DRYAD database. The study was conducted at the Santa Clara Valley Medical Center (SCVMC). Data on preterm babies whose gestational age (GA) was &lt;\u200934 weeks were collected prospectively from January 2008 to February 2014. Logistic regression was applied to explore the association between HCT2h and ROP.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      A total of 326 very preterm infants born at or earlier than 34 weeks were included. The incidence of any ROP was 23.9%, and the incidence of severe ROP was 4.6%. The HCT2h, birth weight, GA, Apgar1 min, and Apgar5 min of any ROP group were significantly lower than those of preterm babies without ROP (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Sex differences, the rate of multiples, and delivery mode between the two groups were not statistically significant (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&gt;\u20090.05). We classified HCT2h into three levels, and after multivariate logistic regression, we found that high HCT2h remained a significant protective factor against ROP (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001). Through subgroup analysis, we observed that among preterm infants with a GA of 28 weeks or more, there was a significant inverse association between a 1% increase in HCT2h and a 17% reduction in the occurrence of ROP.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>We found that HCT2h may be an effective biomarker for identifying the risk of ROP of very preterm infants born between 28 and 34 weeks of gestation.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial registration<\/jats:title>\n                    <jats:p>This was a retrospective study and the data were from the DRYAD database. Santa Clara Valley Medical Center\u2019s (SCVMC) ethical committee reviewed and approved the studies involving human participants. Informed consent was waived for this study. We did not perform any extra interventions.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-025-05533-8","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:02:46Z","timestamp":1741392166000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Association between hematocrit in the first two hours of life and retinopathy during prematurity: a retrospective study from DRYAD"],"prefix":"10.1186","volume":"25","author":[{"given":"Xiaohui","family":"Kong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huabin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ru","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chengshuai","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lihua","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xueyun","family":"Ren","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2025,3,8]]},"reference":[{"key":"5533_CR1","doi-asserted-by":"crossref","unstructured":"Prasad M, Ingolfsland EC, Christiansen SP. Modifiable risk factors and preventative strategies for severe retinopathy of prematurity. Life 2023, 13(5).","DOI":"10.3390\/life13051075"},{"issue":"6","key":"5533_CR2","doi-asserted-by":"publisher","first-page":"1216","DOI":"10.1038\/s41372-021-01015-8","volume":"41","author":"EH Wood","year":"2021","unstructured":"Wood EH, Chang EY, Beck K, Hadfield BR, Quinn AR, Harper CA. 80 Years of vision: preventing blindness from retinopathy of prematurity. J Perinatol. 2021;41(6):1216\u201324.","journal-title":"J Perinatol"},{"issue":"5","key":"5533_CR3","doi-asserted-by":"publisher","first-page":"3434","DOI":"10.1167\/iovs.13-11837","volume":"54","author":"SJ Woo","year":"2013","unstructured":"Woo SJ, Park KH, Lee SY, Ahn SJ, Ahn J, Park KH, Oh KJ, Ryu A. The relationship between cord blood cytokine levels and perinatal factors and retinopathy of prematurity: a gestational age-matched case-control study. Invest Ophthalmol Vis Sci. 2013;54(5):3434\u20139.","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"3","key":"5533_CR4","doi-asserted-by":"publisher","first-page":"950","DOI":"10.1038\/s41390-023-02568-4","volume":"94","author":"C Fung","year":"2023","unstructured":"Fung C, Cung T, Nelson C, Wang H, Bretz C, Ramshekar A, Brown A, Stoddard GJ, Hartnett ME. Retinopathy of prematurity protection conferred by uteroplacental insufficiency through erythropoietin signaling in an experimental murine model. Pediatr Res. 2023;94(3):950\u20135.","journal-title":"Pediatr Res"},{"key":"5533_CR5","doi-asserted-by":"crossref","unstructured":"Bal S, Ying G-s, Tomlinson L, Binenbaum G. Association of weight gain acceleration with risk of retinopathy of prematurity. JAMA Ophthalmol 2019, 137(11).","DOI":"10.1001\/jamaophthalmol.2019.3447"},{"issue":"1","key":"5533_CR6","doi-asserted-by":"publisher","first-page":"22321","DOI":"10.1038\/s41598-021-01861-8","volume":"11","author":"AC Almeida","year":"2021","unstructured":"Almeida AC, Silva GA, Santini G, Brizido M, Correia M, Coelho C, Borrego LM. Correlation between hyperglycemia and glycated albumin with retinopathy of prematurity. Sci Rep. 2021;11(1):22321.","journal-title":"Sci Rep"},{"issue":"1","key":"5533_CR7","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1055\/s-0038-1627097","volume":"36","author":"JM Edwards","year":"2019","unstructured":"Edwards JM, Edwards LE, Swamy GK, Grotegut CA. Effect of cord blood magnesium level at birth on Non-neurologic neonatal outcomes. Am J Perinatol. 2019;36(1):3\u20137.","journal-title":"Am J Perinatol"},{"issue":"1","key":"5533_CR8","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1159\/000512282","volume":"118","author":"G Hellgren","year":"2021","unstructured":"Hellgren G, Lundgren P, Pivodic A, L\u00f6fqvist C, Nilsson AK, Ley D, S\u00e4vman K, Smith LE, Hellstr\u00f6m A. Decreased platelet counts and serum levels of VEGF-A, PDGF-BB, and BDNF in extremely preterm infants developing severe ROP. Neonatology. 2021;118(1):18\u201327.","journal-title":"Neonatology"},{"issue":"31","key":"5533_CR9","doi-asserted-by":"publisher","first-page":"e26765","DOI":"10.1097\/MD.0000000000026765","volume":"100","author":"S Romero-Maldonado","year":"2021","unstructured":"Romero-Maldonado S, Montoya-Estrada A, Reyes-Munoz E, Guzman-Grenfell AM, Torres-Ramos YD, Sanchez-Mendez MD, Tolentino-Dolores M, Salgado-Valladares MB, Belmont-Gomez A, Najera N, et al. Efficacy of water-based vitamin E solution versus placebo in the prevention of retinopathy of prematurity in very low birth weight infants: A randomized clinical trial. Med (Baltim). 2021;100(31):e26765.","journal-title":"Med (Baltim)"},{"issue":"4","key":"5533_CR10","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1001\/jamapediatrics.2020.5653","volume":"175","author":"A Hellstrom","year":"2021","unstructured":"Hellstrom A, Nilsson AK, Wackernagel D, Pivodic A, Vanpee M, Sjobom U, Hellgren G, Hallberg B, Domellof M, Klevebro S, et al. Effect of enteral lipid supplement on severe retinopathy of prematurity: A randomized clinical trial. JAMA Pediatr. 2021;175(4):359\u201367.","journal-title":"JAMA Pediatr"},{"issue":"9","key":"5533_CR11","doi-asserted-by":"publisher","first-page":"e0138829","DOI":"10.1371\/journal.pone.0138829","volume":"10","author":"D Song","year":"2015","unstructured":"Song D, Jegatheesan P, DeSandre G, Govindaswami B. Duration of cord clamping and neonatal outcomes in very preterm infants. PLoS ONE. 2015;10(9):e0138829.","journal-title":"PLoS ONE"},{"key":"5533_CR12","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.2147\/OPTH.S301439","volume":"15","author":"CS Carranza-Mendizabal","year":"2021","unstructured":"Carranza-Mendizabal CS, Diaz-Manrique M, Ruiz Mamani PG, White M, Huancahuire-Vega S. Incidence and risk factors associated with retinopathy of prematurity in Peru. Clin Ophthalmol. 2021;15:2141\u20138.","journal-title":"Clin Ophthalmol"},{"key":"5533_CR13","doi-asserted-by":"crossref","unstructured":"Parrozzani R, Nacci EB, Bini S, Marchione G, Salvadori S, Nardo D, Midena E. Severe retinopathy of prematurity is associated with early post-natal low platelet count. Sci Rep 2021, 11(1).","DOI":"10.1038\/s41598-020-79535-0"},{"issue":"2","key":"5533_CR14","doi-asserted-by":"publisher","first-page":"138","DOI":"10.1136\/archdischild-2018-316464","volume":"105","author":"MG Gantz","year":"2020","unstructured":"Gantz MG, Carlo WA, Finer NN, Rich W, Faix RG, Yoder BA, Walsh MC, Newman NS, Laptook A, Schibler K, et al. Achieved oxygen saturations and retinopathy of prematurity in extreme preterms. Arch Dis Child Fetal Neonatal Ed. 2020;105(2):138\u201344.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"5533_CR15","doi-asserted-by":"crossref","unstructured":"Tandon M, Ranjan R, Muralidharan U, Kannan A. Influence of anaemia on multifactorial disease retinopathy of prematurity: A prospective observational study. Cureus; 2022.","DOI":"10.7759\/cureus.27877"},{"issue":"1","key":"5533_CR16","doi-asserted-by":"publisher","first-page":"1010","DOI":"10.1186\/s13063-022-06949-8","volume":"23","author":"L Teofili","year":"2022","unstructured":"Teofili L, Papacci P, Orlando N, Bianchi M, Pasciuto T, Mozzetta I, Palluzzi F, Giaco L, Giannantonio C, Remaschi G, et al. BORN study: a multicenter randomized trial investigating cord blood red blood cell transfusions to reduce the severity of retinopathy of prematurity in extremely low gestational age neonates. Trials. 2022;23(1):1010.","journal-title":"Trials"},{"issue":"2","key":"5533_CR17","doi-asserted-by":"publisher","first-page":"56","DOI":"10.3345\/kjp.2019.00990","volume":"63","author":"EY Lee","year":"2020","unstructured":"Lee EY, Kim SS, Park GY, Lee SH. Effect of red blood cell transfusion on short-term outcomes in very low birth weight infants. Clin Experimental Pediatr. 2020;63(2):56\u201362.","journal-title":"Clin Experimental Pediatr"},{"issue":"8","key":"5533_CR18","doi-asserted-by":"publisher","first-page":"1089","DOI":"10.1038\/s41372-019-0408-8","volume":"39","author":"D Knee","year":"2019","unstructured":"Knee D, Knoop S, Davis AT, Rawson B, DiCarlo A, Olivero R. Outcomes after implementing restrictive blood transfusion criteria in extremely premature infants. J Perinatol. 2019;39(8):1089\u201397.","journal-title":"J Perinatol"},{"issue":"5","key":"5533_CR19","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1159\/000512020","volume":"117","author":"T Hengartner","year":"2020","unstructured":"Hengartner T, Adams M, Pfister RE, Snyers D, McDougall J, Waldvogel S, Held-Egli K, Spring L, Rogdo B, Riedel T, et al. Associations between red blood cell and platelet transfusions and retinopathy of prematurity. Neonatology. 2020;117(5):562\u20138.","journal-title":"Neonatology"},{"key":"5533_CR20","doi-asserted-by":"crossref","unstructured":"Fauchere JC, Koller BM, Tschopp A, Dame C, Ruegger C, Bucher HU, Swiss Erythropoietin Neuroprotection Trial G. Safety of early High-Dose Recombinant erythropoietin for neuroprotection in very preterm infants. J Pediatr. 2015;167(1):52\u20137. e51-53.","DOI":"10.1016\/j.jpeds.2015.02.052"},{"key":"5533_CR21","doi-asserted-by":"crossref","unstructured":"Dani C, MFR, Bertini G, Martelli E, Pezzati M, Rubaltelli FF. The role of blood transfusions and iron intake on retinopathy of prematurity. Early Hum Dev. 2001;62(2001):57\u201363.","DOI":"10.1016\/S0378-3782(01)00115-3"},{"key":"5533_CR22","doi-asserted-by":"crossref","unstructured":"Aher SM, Ohlsson A. Early versus late erythropoietin for preventing red blood cell transfusion in preterm and\/or low birth weight infants. Cochrane Database of Systematic Reviews 2020, 2020(2).","DOI":"10.1002\/14651858.CD004865.pub4"},{"key":"5533_CR23","doi-asserted-by":"crossref","unstructured":"Pellegrino C, Papacci P, Beccia F, Serrao F, Cantone GV, Cannetti G, Giannantonio C, Vento G, Teofili L. Differences in cerebral tissue oxygenation in preterm neonates receiving adult or cord blood red blood cell transfusions. JAMA Netw Open 2023, 6(11).","DOI":"10.1001\/jamanetworkopen.2023.41643"},{"issue":"12","key":"5533_CR24","doi-asserted-by":"publisher","first-page":"2507","DOI":"10.1111\/apa.16965","volume":"112","author":"K Glaser","year":"2023","unstructured":"Glaser K, H\u00e4rtel C, Dammann O, Herting E, Andres O, Speer CP, G\u00f6pel W, Stahl A. Erythrocyte transfusions are associated with retinopathy of prematurity in extremely low gestational age newborns. Acta Paediatr. 2023;112(12):2507\u201315.","journal-title":"Acta Paediatr"},{"key":"5533_CR25","doi-asserted-by":"crossref","unstructured":"Torrejon-Rodriguez L, Pinilla-Gonzalez A, Lara Cant\u00f3n I, Albiach-Delgado A, Cascant-Vilaplana MM, Cernada M, Kuligowski J, Solves Alcaina MP, G\u00f3mez I, Vento M et al. Effect of autologous umbilical cord blood transfusion in the development of retinopathy of prematurity: randomized clinical trial \u2013 study protocol. Front Pead 2023, 11.","DOI":"10.3389\/fped.2023.1269797"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05533-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-05533-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-05533-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T00:02:52Z","timestamp":1741392172000},"score":1,"resource":{"primary":{"URL":"https:\/\/bmcpediatr.biomedcentral.com\/articles\/10.1186\/s12887-025-05533-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,8]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["5533"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-05533-8","relation":{"has-preprint":[{"id-type":"doi","id":"10.21203\/rs.3.rs-4141695\/v1","asserted-by":"object"}]},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,8]]},"assertion":[{"value":"21 March 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 February 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 March 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The ethical committee of the Affiliated Hospital of Jining Medical University reviewed and approved the study (2024C134), and informed consent was waived.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"176"}}